FDA Inspection
Carle Health Care Inc Reproductive Reproductive WindsorCarle Health Care Inc Reproductive Reproductive Windsor – FDA Inspection, Aug 15, 2018
Record Details
This FDA Inspection record concerns Carle Health Care Inc Reproductive Reproductive Windsor, with an inspection on August 15, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- August 15, 2018
- Product Type
- Biologics
View Company Profile
ID · fbc9e88c-068d-48ee-8742-d7e0398b4248
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1063414
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 1271.90(c)Eligibility not required--warning labels
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Carle Health Care Inc Reproductive Reproductive Windsor
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 24, 2026 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 8, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| April 11, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 13, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Carle Health Care Inc Reproductive Reproductive Windsor
- FDA Inspection 1335568 - 2026-08-24
- FDA Inspection 1190733 - 2022-11-08
- FDA Inspection 968472 - 2016-04-11
- FDA Inspection 883128 - 2014-06-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.